Recombinant multi-species GDI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GDI1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
GDP dissociation inhibitors are proteins that regulate the GDP-GTP exchange reaction of members of the rab family, small GTP-binding proteins of the ras superfamily, that are involved in vesicular trafficking of molecules between cellular organelles. GDIs slow the rate of dissociation of GDP from rab proteins and release GDP from membrane-bound rabs. GDI1 is expressed primarily in neural and sensory tissues. Mutations in GDI1 have been linked to X-linked nonspecific cognitive disability. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1A,GDI-1,GDI1,GDIA,GDIL,GDIalpha,Gdi1,Guanosine diphosphate dissociation inhibitor 1 (GDI-1),MRX41,MRX48,OPHN2,Oligophrenin-2,Protein XAP-4,RABGD1A,RABGDIA,Rab GDI alpha,Rab GDP dissociation inhibitor alpha,XAP-4,XLID41
Go
to GDI1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP7376-Ag-1/ GM-Tg-hg-IP7376-Ag-2 | Human GDI1 protein | Human |
GM-Tg-rg-IP7376-Ag-1/ GM-Tg-rg-IP7376-Ag-2 | Rat GDI1 protein | Rat |
GM-Tg-mg-IP7376-Ag-1/ GM-Tg-mg-IP7376-Ag-2 | Mouse GDI1 protein | Mouse |
GM-Tg-cynog-IP7376-Ag-1/ GM-Tg-cynog-IP7376-Ag-2 | Cynomolgus/Rhesus macaque GDI1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP7376-Ag-1/ GM-Tg-felg-IP7376-Ag-2 | Feline GDI1 protein | Feline |
GM-Tg-cang-IP7376-Ag-1/ GM-Tg-cang-IP7376-Ag-2 | Canine GDI1 protein | Canine |
GM-Tg-bovg-IP7376-Ag-1/ GM-Tg-bovg-IP7376-Ag-2 | Bovine GDI1 protein | Bovine |
GM-Tg-equg-IP7376-Ag-1/ GM-Tg-equg-IP7376-Ag-2 | Equine GDI1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP7376-Ag-1/ GM-Tg-hg-IP7376-Ag-2;
GM-Tg-rg-IP7376-Ag-1/ GM-Tg-rg-IP7376-Ag-2;
GM-Tg-mg-IP7376-Ag-1/ GM-Tg-mg-IP7376-Ag-2; GM-Tg-cynog-IP7376-Ag-1/ GM-Tg-cynog-IP7376-Ag-2; GM-Tg-felg-IP7376-Ag-1/ GM-Tg-felg-IP7376-Ag-2; GM-Tg-cang-IP7376-Ag-1/ GM-Tg-cang-IP7376-Ag-2; GM-Tg-bovg-IP7376-Ag-1/ GM-Tg-bovg-IP7376-Ag-2; GM-Tg-equg-IP7376-Ag-1/ GM-Tg-equg-IP7376-Ag-2 |
Products Name | GDI1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | GDI1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GDI1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.